Abstract

With recent successes of immunotherapies and targeted drugs, melanoma has become one of the most dynamic areas of anticancer drug development.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call